| Name | Title | Contact Details |
|---|---|---|
Michelle Littlewood |
Vice President, People and Experience | Profile |
MaryAnn Holbert |
Vice President, People | Profile |
Jennifer Fox |
Chief of Staff | Profile |
Virobay is focused on the development and commercialization of novel drugs through the utilization of small molecule inhibitors of cysteine proteases, a diverse class of enzyme proteases, for a variety of conditions, including neuropathic pain, autoimmune diseases and fibrosis. The foundation of Virobay's proprietary cathepsin platform and the Virobay management team were spun-out from Celera Genomics, which was then a leader in cathepsin research. Virobay's clinical pipeline currently includes product candidates in neuropathic pain, dermatology, autoimmune disease and fibrosis.
WHPM Biotech is a El Monte, CA-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
Engineering next‑generation, brain‑penetrant cancer therapies.
Managed by Battelle National Biodefense Institute (BNBI) as a Federally Funded Research and Development Center (FFRDC), National Biodefense Analysis and Countermeasures Center is the first laboratory built for DHS – a national resource to understand th...
Ikena Oncology is a clinical-stage biotechnology company that discovers and develops patient-directed, biomarker-driven therapies for cancer patients.